Consistent with the decrease in tumor volume shown in Fig. 2d, we found significant downregulation of the proliferation marker Ki67 in the tumors from the PyMT-Mbd2−/− group compared to those from the wild-type group (Fig. 2g). Here, MBD2 is linked to neoplasm.